Dr. Michael Zvolensky, Ph.D.
Claim this profileRESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity
Affiliated Hospitals
RESTORE Laboratory: Research On Emotion, Substance Treatment Outcomes, And Racial Equity
Anxiety And Health Research Laboratory And Substance Use Treatment Clinic, University Of Houston
Clinical Trials Michael Zvolensky, Ph.D. is currently running
Personalized Feedback Intervention
for Anxiety and Hazardous Drinking
The purpose of this study is to develop, evaluate the acceptability/feasibility (Phase IA), and test (Phase IB) the effectiveness of a brief, integrated, single-session, computer-based, culturally adapted personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with anxiety.
Recruiting
1 award
N/A
6 criteria
Mobile App
for Alcoholism
The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.
Recruiting
1 award
N/A
1 criteria
More about Michael Zvolensky, Ph.D.
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Michael Zvolensky, Ph.D. has experience with
- EASE App
- INSIGHT (Control) App
- Educational Videos
- QuitGuide App + NRT
- MASP App
- QuitGuide App
Breakdown of trials Michael Zvolensky, Ph.D. has run
Alcohol-Related Intimate Partner Violence
Anxiety Disorders
Alcoholism
Anxiety
Coronavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Zvolensky, Ph.D. specialize in?
Michael Zvolensky, Ph.D. focuses on Alcohol-Related Intimate Partner Violence and Anxiety Disorders. In particular, much of their work with Alcohol-Related Intimate Partner Violence has involved treating patients, or patients who are undergoing treatment.
Is Michael Zvolensky, Ph.D. currently recruiting for clinical trials?
Yes, Michael Zvolensky, Ph.D. is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Michael Zvolensky, Ph.D. has studied deeply?
Yes, Michael Zvolensky, Ph.D. has studied treatments such as EASE app, INSIGHT (Control) App, Educational Videos.
What is the best way to schedule an appointment with Michael Zvolensky, Ph.D.?
Apply for one of the trials that Michael Zvolensky, Ph.D. is conducting.
What is the office address of Michael Zvolensky, Ph.D.?
The office of Michael Zvolensky, Ph.D. is located at: RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity, Houston, Texas 77204 United States. This is the address for their practice at the RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.